In recent years, the biotech industry has seen remarkable expansion and innovation. Alongside this growth, the role of CFOs in the sector has transformed, bringing along unique challenges and plenty of opportunities to positively impact their companies' success. Want to understand how to navigate and triumph over these challenges and opportunities? Gain insights from Ozan Pamir, a voice of experience and expertise in the field.
Ozan holds the position of Chief Financial Officer at 180 Life Sciences, playing a crucial role in successfully listing the company on NASDAQ and overseeing most of its funding rounds. He possesses a rich history of helping companies in defining their corporate strategies and skillfully navigating corporate transactions, including M&A and IPOs. Ozan was a Board Member and CFO at Unify Pharmaceuticals, Chief Financial officer at Enosi Life Sciences, Professional Member Committee Member at CFA Society Toronto, and VP of Investment Banking at Echelon Wealth Partners.
In this episode, we discuss:
- Challenges CFOs face in biotech
- What does the modern CFO profile encompass?
- Key qualities CFOs seek in potential team members within biotech
- How can CFOs navigate challenging economic times?
Learn more about Ozan:
Episode resources:
If you enjoyed this episode, then please either:
Instructions on how to follow, rate, and review CFO Weekly are
here.
Episode resources:
If you enjoyed this episode, then please either:
Instructions on following, rating, and reviewing CFO Weekly are
here.
Previous guests include:
Tom McDermott, CFO at Career Certified,
Claire Bramley, CFO at Teradata,
Chris Miles, Founder of Money Ripples,
Ranil DeSilva, CFO & COO at CARE,
Jordan Grumet, Financial Independence Expert & Host of Earn & Invest &
William Washington, Global CFO at Baker McKenzie
Check out some of our most recent episodes:
If you are interested in joining CFO Weekly as a guest, please complete this form:
fame.so/cfo-guestCFO Weekly is handcrafted by our friends over at:
fame.so
